Wu Yan, Strawn Estil, Basir Zainab, Wang Yuedong, Halverson Gloria, Jailwala Parthav, Guo Sun-Wei
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisc. 53226-0509, USA.
Gynecol Obstet Invest. 2006;62(3):148-59. doi: 10.1159/000093130. Epub 2006 May 5.
BACKGROUND/AIMS: Ectopic and eutopic endometria of women with endometriosis have been shown to contain genomic alterations. In this study, we sought to identify genomic alterations in both ectopic and eutopic endometria of 5 women with endometriosis and to examine whether the two tissues share any genomic alterations. We also attempted to classify tissue samples based on the alteration profiles.
Laser capture microdissection was used to harvest epithelial cells. High-resolution comparative genomic hybridization microarrays were used to identify genomic alterations in eutopic and ectopic endometria from 5 women with endometriosis. The results were validated by real-time RT-PCR and loss of heterozygosity analysis.
All 5 patients had genomic alterations in their eutopic and ectopic endometria. The ectopic and eutopic endometria shared a sizable portion of genomic alterations. Cluster analysis of the genomic alteration profile correctly and consistently classified tissue samples from the 5 patients into two groups: peritoneal implants and ovarian cysts.
The correct classification of tissue samples into two groups suggests that these two subtypes of endometriosis may have distinct genomic alteration profiles and are thus distinct entities, as previously proposed. The shared alterations are likely the ones that harbor genes responsible for an increased propensity of endometrial debris to implant to the ectopic sites and for early events that lead to the establishment of lesions. Alternatively, these shared alterations may harbor genes that are dysregulated in both eutopic and ectopic endometria. The identified genomic alterations should help to zero in genes involved in the pathogenesis of endometriosis in future studies.
背景/目的:子宫内膜异位症患者的异位和在位内膜已被证明存在基因组改变。在本研究中,我们试图鉴定5例子宫内膜异位症患者的异位和在位内膜中的基因组改变,并检查这两种组织是否存在共同的基因组改变。我们还尝试根据改变图谱对组织样本进行分类。
使用激光捕获显微切割技术获取上皮细胞。利用高分辨率比较基因组杂交微阵列鉴定5例子宫内膜异位症患者在位和异位内膜中的基因组改变。结果通过实时逆转录-聚合酶链反应和杂合性缺失分析进行验证。
所有5例患者的在位和异位内膜均存在基因组改变。异位和在位内膜有相当一部分基因组改变是相同的。对基因组改变图谱进行聚类分析,正确且一致地将5例患者的组织样本分为两组:腹膜种植灶和卵巢囊肿。
将组织样本正确分为两组表明,这两种子宫内膜异位症亚型可能具有不同的基因组改变图谱,因此是不同的实体,正如之前所提出的那样。共同的改变可能涉及那些使子宫内膜碎片易于种植到异位部位以及导致病变形成的早期事件的相关基因。或者,这些共同的改变可能涉及在位和异位内膜中均失调的基因。所鉴定的基因组改变应有助于在未来的研究中确定参与子宫内膜异位症发病机制的基因。